*David P Obert1,2, Gwi H Park1,2, Kathleen F Vincent1,2, Ken Solt1,2 (1. Harvard Medical School, 2. Massachusetts General Hospital)
Session information
[CINP2024] Poster Session
CINP2024 » Poster Session
Addiction Disorders 5 - Preclinical
Sun. May 26, 2024 1:30 PM - 2:30 PM CINP Poster Session Hall (Lobby Gallery)
*Wei Zheng1, Tangsheng Lu3, Yanxue Xue3, Lin Lu1,2,3 (1. Peking-Tsinghua Centre for Life Sciences and PKU-IDG/McGovern Institute for Brain Research, Peking University, Beijing, 100871, China, 2. National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University Sixth Hospital, Peking University Institute of Mental Health, Beijing 100191,China, 3. National Institute on Drug Dependence, Beijing Key Laboratory of Drug Dependence, Peking University, Beijing 100191, China)
*Hwei-Hsien Chen1, Mei-Yi Lee1, Ching-Yi Chen1, Yung-Ting Hung1 (1. Center for Neuropsychiatric Research, National Health Research Institutes, Zhunan, Taiwan)
*Saya Arakaki1, Aoi Mori1, Masabumi Minami1 (1. Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Japan.)
*Hao-Yuan Hung1, Ya-Wun You1, Lih-Chu Chiou2 (1. National Defense Medical Center, 2. National Taiwan University)
*YUN TING HUNG1, Mei Yi Lee1, Ming Huan Chan2, Hwei Hsien Chen1 (1. National Health Research Institutes, 2. INSTITUTE OF NEUROSCIENCE, NATIONAl CHENGCHI UNIVERSITY)
*Naoya Nishitani1,2, Taisuke Kokume2, Harumi Taniguchi1, Katsuyuki Kaneda1,2 (1. Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, 2. Laboratory of Molecular Pharmacology, School of Pharmaceutical Sciences, Kanazawa University)
*Soyon Ahn1, Haiyan Zou1, Anthony G. Phillips1 (1. University of British Columbia)
*Shinya Kasai1,2,3, Daisuke Nishizawa3, Susumu Higuchi4, Kazutaka Ikeda3 (1. Department of Biotechnology, Faculty of Life and Environmental Sciences, University of Yamanashi, 2. Center for Advanced Assisted Reproductive Technologies, University of Yamanashi, 3. Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 4. National Hospital Organization Kurihama Medical and Addiction Center)
*Woraphat Ratta-apha1, Nutthaya Bunmak1, Witchuda Saengsawang1, Arthit Chairoungdua1, Thet Tun Zaw, Apichart Ranuwattananon2, Rasmon Kalayasiri3 (1. Mahidol University, Bangkok, Thailand, 2. Princess Mother National Institute on Drug Abuse Treatment, Thailand, 3. Chulalongkorn University, Bangkok, Thailand)
*Kazuhei Niitani1, Ryoma Nishida2, Naoya Nishitani1,2, Satoshi Deyama1,2, Katsuyuki Kaneda1,2 (1. Laboratory of Molecular Pharmacology, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan, 2. Laboratory of Molecular Pharmacology, School of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan)
*Liu Xiaoxing1, Lu Tangsheng2, Han Ying2, Lu Lin1,2 (1. Peking University Sixth Hospital, 2. National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence Research)
*WENYU HSU1,2 (1. Post Baccalaureate Medicine, National Chung Hsing University, Taichung, Taiwan, 2. Department of Psychiatry, Changhua Christian Hospital, Changhua, Taiwan)